9 research outputs found
Alemtuzumab for Multiple Sclerosis
- Author
- A Coles
- A Coles
- A Coles
- A Coles
- A Compston
- A Cuker
- AA Pace
- AJ Coles
- AJ Coles
- AJ Coles
- AJ Coles
- AJ Coles
- AJ Coles
- AL Cox
- CL Hirst
- CL McCarthy
- D Rau
- DH Margolin
- E Havari
- EJ Fox
- EJ Fox
- G Hale
- G Hale
- GA Hill-Cawthorne
- GH Daniels
- GM Cheetham
- J Somerfield
- JA Cohen
- JF Kurtzke
- JL Jones
- JL Jones
- JL Jones
- JL Jones
- L Azzopardi
- L Klotz
- M Stanglmaier
- Mark D. Willis
- MD Cossburn
- MD Cossburn
- MD Willis
- MJ Turner
- NA Patsopoulos
- Neil P. Robertson
- NP Robertson
- O Kousin-Ezewu
- O Tuohy
- R Ibitoye
- R Straus Farber
- S Mercanti De
- S Sawcer
- SA Thompson
- SP Rao
- T Moreau
- T Moreau
- T Watanabe
- WC Rowan
- X Zhang
- Y Hu
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
ALAIN01—Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential
- Author
- A Coles
- A Compston
- A Junker
- AGS Buggins
- AJ Coles
- AJ Coles
- AJ Coles
- AL Cox
- Ali Maisam Afzali
- AM Herrmann
- B Arden
- C Pannetier
- Catharina C. Gross
- CL Hirst
- CT Investigators
- E Havari
- E GG Havrdova
- F Powrie
- G Zandman-Goddard
- GG Compston DAS
- H Batoulis
- Heinz Wiendl
- I Peluso
- JA Cohen
- JL Jones
- JL Jones
- JL Jones
- K Gobel
- Karl-Friedrich Lukat
- L Azzopardi
- L Crino
- L Yang
- LE Clough
- Luisa Klotz
- M J-i
- Maria Eveslage
- MD Cossburn
- N Schwab
- Nico Melzer
- O Kousin-Ezewu
- O Tuohy
- R Ettinger
- R Martin
- R Thorne
- S Illes
- SA Thompson
- SG Meuth
- SP Rao
- Stefan Bittner
- Steffen Pfeuffer
- Sven G. Meuth
- T Krupica Jr
- T Moreau
- T Moreau
- T Ruck
- Tobias Ruck
- U Feger
- X Zhang
- Y Hu
- YH Huang
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort
- Author
- Cohen JA
- Coles A
- Coles A
- Coles AJ
- Coles AJ
- Coles AJ
- Coles AJ
- Coles AJ
- Coles AJ
- Coles AJ
- Confavreux C
- Cossburn M
- Cossburn MD
- Fox EJ
- Fox EJ
- Hale G
- Hirst CL
- Hu Y
- J Smee
- KE Harding
- Klotz L
- Kousin-Ezewu O
- M Wardle
- MD Willis
- Medd P
- Moreau T
- Moreau T
- NJ Scolding
- NP Robertson
- OR Pearson
- Pace A
- Poser S
- Rao SP
- Robertson N
- TP Pickersgill
- Tuohy O
- Visscher BR
- Weinshenker BG
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
- Author
- A Cuker
- A Cuker
- A Langer-Gould
- AE Miller
- AJ Coles
- AJ Coles
- AJ Coles
- AJ Coles
- AM Subei
- B Uitdehaag
- BC Kieseier
- BD Trapp
- C Caon
- Celia Oreja-Guevara
- CH Polman
- Chris McGuigan
- CL Hirst
- CL McCarthy
- D Margolin
- DM Wingerchuk
- DS Goodin
- E Havrdova
- EJ Fox
- FC Medeiros de
- G Bloomgren
- H-P Hartung
- HJ Lenz
- Igor Stoliarov
- Irina Elovaara
- JA Cohen
- JR Miller
- K Noyes
- Kjell-Morten Myhr
- L Kappos
- L Kappos
- L Kappos
- L Klotz
- L Mauri-Fabrega
- L McEwan
- Lucia Moiola
- M Clerico
- M Cossburn
- M Hutchinson
- M Mahzari
- MD Cossburn
- MJ Turner
- NP Robertson
- O Kousin-Ezewu
- O Tuohy
- P Gallo
- PRISMS Study Group
- PS Sorensen
- R Bergamaschi
- RA Bermel
- RJ Fox
- SR Schwid
- Sten Fredrikson
- T Vollmer
- TC Frohman
- Thomas Berger
- Uwe K. Zettl
- Y Hu
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis
- Author
- A Bar-Or
- A Baumgartner
- A Kerbrat
- A Langer-Gould
- A Miravalle
- AJ Coles
- AJ Coles
- AJ Coles
- AJ Coles
- AJ Coles
- AL Cox
- Anne H. Cross
- Becky J. Parks
- BK Kleinschmidt-DeMasters
- BK Kleinschmidt-DeMasters
- BM Segal
- BM Segal
- BO Khatri
- BW Oosten van
- BW Oosten van
- CF Lucchinetti
- CH Polman
- D Wynn
- DB Clifford
- DH Miller
- DJ Cua
- E Kabat
- Erin E. Longbrake
- G Bloomgren
- G Kohler
- H Lindå
- HP Brok
- I Ayzenberg
- IL Tan
- J Somerfield
- JA Cohen
- JL Teeling
- K Hawker
- K Selmaj
- L Gorelik
- L Kappos
- L Riechmann
- M Cossburn
- MD Cossburn
- MH Gilleece
- MM Esiri
- MM Vellinga
- MR Clatworthy
- NF Blair
- NH Ruddle
- OW Howell
- P Rieckmann
- P Rieckmann
- P Stashenko
- PS Sørensen
- PW O'Connor
- R Gold
- R Phan-Ba
- RA Rudick
- RT Naismith
- SA Thompson
- SJ Kent
- SJ Kent
- SL Hauser
- T Johnson
- T Rispens
- TA Yednock
- The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group
- TR Malek
- V Rigau
- WA Sheremata
- X Bosch
- Y Kuroda
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals
- Author
- A Hayashi
- A Parrella
- A Ranade
- A Rao
- A Serretti
- AJ Pollock
- AJ Zillich
- Ammara Saleem
- B Hellman
- B Huerta
- B Shine
- B Zafrir
- C Gupta
- C Massart
- CA Sklar
- DC Rizzo
- DM Kristensen
- E Mezosi
- E Moutzouri
- EL Batcher
- F Labrie
- F Radi
- FD Gianfrancesco
- G Barbesino
- G Danaei
- GQ Phan
- Group NDD
- GS Malhi
- H Bennet
- I Ben-Aharon
- IT Huhtaniemi
- J Desai
- J Mortensen
- J Müller
- J Toppari
- JA Mennigen
- JH Lazarus
- JI Barzilay
- JJ Heindel
- JO Tijani
- K Bay
- K Nakamura
- L Bartalena
- L Røste
- L Trasande
- M Cossburn
- M Gonzalez-Rey
- M Laakso
- M Liu
- M Welsh
- MB Frungieri
- MB Kjærstad
- MD Anway
- MD Guenette
- MD Trip
- MJ Benotti
- MM Dobrzyńska
- MS Jensen
- Muhammad Furqan Akhtar
- N Caraccio
- O Albert
- OJ Phung
- P Alonso-Magdalena
- P Andreone
- P Gareri
- P Prasad
- R Ivell
- R Mitchell
- R Rao
- RB Burikhanov
- RF McKnight
- RL Cooper
- RW Benjamin
- S Berens
- S De-Wit
- S Haliakon
- S Han
- S Kinoshita
- S Mazaud-Guittot
- S Mostafalou
- S Svalheim
- SA Hamed
- Shakila Sabir
- SW Keith
- T Masaki
- T Soga
- T Takano
- T Vial
- T Zornitzki
- TT Brown
- VF Garry
- W Wiersinga
- WK Kroeze
- WS Leslie
- X Gao
- X Gao
- X Xiaotian
- Z Liew
- Ž Aleksić
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage Agents
- Author
- A Bar-Or
- A Bar-Or
- A Bar-Or
- A Coles
- A Traboulsee
- AA Othman
- AJ Coles
- AJ Coles
- AJ Coles
- AJ Coles
- AR Almeida
- B Barun
- B Bielekova
- B Serafini
- BH Nelson
- BK Kleinschmidt-DeMasters
- C Baecher-Allan
- CH Polman
- CL McCarthy
- CS Constantinescu
- D Cadavid
- D Mehta
- D Rau
- D Wynn
- DH Miller
- DJ Huss
- DR Anderson
- E Havrdova
- EF Mysler
- ES Molloy
- F Curtin
- FB Vincent
- G Disanto
- G Giovannoni
- G Giovannoni
- G Hale
- I Metz
- IV Gupta
- J Elkins
- J Goebel
- J Paues
- J Romme Christensen
- J Salzer
- J Salzer
- JA Cohen
- JD Fontenot
- JD Fontenot
- JF Martin
- JG Krueger
- JJ Archelos
- JL Jones
- JP Sheridan
- JQ Tran
- K Hawker
- L Azzopardi
- L Isidoro
- L Kappos
- L Kappos
- L Kappos
- L Kappos
- M Minocha
- MD Cossburn
- MD Willis
- ME Reff
- Morten Blinkenberg
- NP Robertson
- O Tuohy
- P Alping
- P Emery
- P Flon de
- P Soelberg Sorensen
- P Sorensen
- P Stashenko
- PC Taylor
- Per Soelberg Sørensen
- PJ Mease
- PS Sorensen
- PS Sorensen
- PS Sorensen
- PS Sorensen
- R Gold
- R Gold
- R Setoguchi
- R Temple
- RA Clynes
- S Crotty
- S Hori
- S Mercanti De
- SA Thompson
- SC Wuest
- SG Tangye
- SI Martin
- SL Hauser
- SLCC Hauser
- SP Rao
- T Castillo-Trivino
- T Menge
- T Ruck
- TA Waldmann
- TR Malek
- X Montalban
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study